| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Watts Ryan J. is a President And CEO at Denali Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 41 sells.
Estimated insider holdings value: $6.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,334 | $66.35 | $1,216,550.93 | -0.1% | |
| Feb 11, 2021 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 9,473 | $70.30 | $665,984.48 | -0.2% | |
| Feb 9, 2021 | DNLI Denali Therapeutics Inc. | President And CEO | Sale+OE | 5,112 | $73.79 | $377,211.14 | - | |
| Feb 1, 2021 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,334 | $68.44 | $1,254,818.65 | -0.3% | |
| Jan 4, 2021 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 88,334 | $74.96 | $6,621,781.67 | -0.2% | |
| Mar 30, 2020 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 4,807 | $19.48 | $93,640.36 | -17.9% | |
| Dec 4, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 21,268 | $18.00 | $382,874.26 | -0.4% | |
| Nov 25, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 43,485 | $18.02 | $783,573.70 | -0.9% | |
| Sep 5, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 8,581 | $18.05 | $154,894.23 | -0.2% | |
| Jul 1, 2019 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 18,333 | $20.76 | $380,593.08 | -0.7% |